Q: What was the study design?

Small randomised controlled trial (parallel group, 9 per arm) in elite judokas, 4 weeks duration. This sits reasonably high on the hierarchy for internal validity (randomised, controlled) but the n is closer to a pilot/feasibility study than a definitive efficacy trial.

Q: How trustworthy is the methodology?

With only 9 athletes per arm and a mixed-sex, mixed-weight-category sample, the trial is underpowered for most of its secondary physiological outcomes (CK, TNF-alpha, cortisol, HRV), and the cortisol 'interaction without clear post hoc differences' is a tell that the data were noisy relative to the sample size. Blinding of training model is impossible by design, there's no mention of a prior power calculation or correction for the large number of outcome comparisons (CMJ, two power tests, SJFT, internal load, HRV, well-being, three blood markers), which inflates the chance that the one significant power finding (d=0.90) is a lucky draw. A clinician trying to verify this in practice would need the actual CMJ/power numbers and CIs, not just the p-value, to judge whether the gain is meaningfully large.

Q: What is the overall appraisal?

The effect size for lower-limb power (d=0.90) looks large, but in a 9-person group that estimate has huge uncertainty, and it didn't translate into better judo-specific performance on the SJFT, where both models were equivalent. That disconnect matters more clinically than the power finding: if the on-mat outcome is identical, the extra autonomic strain from block planning (higher HRVcv) is a cost without a demonstrated benefit for the outcome coaches actually care about. Creatine kinase and TNF-alpha rose over time in both groups rather than more in block planning specifically, and the cortisol interaction had no clear post hoc differences, so the biochemical picture is murkier than the autonomic one and shouldn't be read as a clean block-planning penalty.

Q: What is the main limitation?

The trial is 4 weeks long with no follow-up into competition or a subsequent training block, so it can't say whether block planning's power gain holds up, decays, or converts into injury or overtraining risk over a full season. The sample is also small and skewed toward men (14 men, 4 women, 9 per arm), so it can't speak to whether the pattern holds for female judokas specifically.

Q: What should clinicians do on Monday?

Not a reason to change a periodization model on Monday. If anything it's a mild argument for favouring undulating planning in a short in-season block for judokas, since it matched block planning on the judo-specific test with less autonomic disruption, but this is one small trial and shouldn't override a coach's existing athlete-specific monitoring.

Q: How do I apply this in practice?

Applies to elite and sub-elite combat-sport athletes (judo, wrestling, grappling) training through short in-season strength blocks where mat time and recovery capacity are both limited. On the S&C floor, this isn't grounds to abandon block periodization, but it does support defaulting to undulating/non-linear loading in-season when technical-tactical volume is already high and recovery monitoring is thin, saving concentrated block loading for off-season or pre-competition windows where the extra autonomic cost can be tracked and managed. In the clinic, treat the HRVcv finding as a cue to monitor autonomic load, not just session RPE or jump output, in athletes on short concentrated strength blocks, especially in the weeks before a competition taper. Treat this as one small trial: don't restructure an athlete's whole periodization model on it, and keep individual recovery monitoring as the actual decision driver.

Question 1

What did the study find?

Accepted Answer

Both groups improved the judo-specific fitness test (SJFT) equally (p<0.01, no between-group difference). Block planning increased lower-limb peak power (p=0.01, d=0.90) while undulating planning did not, but block planning also produced greater heart rate variability disruption (HRVcv, p=0.04) and no clearer recovery profile on creatine kinase or TNF-alpha, both of which rose over time in both groups (p≤0.05).

Question 2

What was the study design?

Accepted Answer

Small randomised controlled trial (parallel group, 9 per arm) in elite judokas, 4 weeks duration. This sits reasonably high on the hierarchy for internal validity (randomised, controlled) but the n is closer to a pilot/feasibility study than a definitive efficacy trial.

Question 3

How trustworthy is the methodology?

Accepted Answer

With only 9 athletes per arm and a mixed-sex, mixed-weight-category sample, the trial is underpowered for most of its secondary physiological outcomes (CK, TNF-alpha, cortisol, HRV), and the cortisol 'interaction without clear post hoc differences' is a tell that the data were noisy relative to the sample size. Blinding of training model is impossible by design, there's no mention of a prior power calculation or correction for the large number of outcome comparisons (CMJ, two power tests, SJFT, internal load, HRV, well-being, three blood markers), which inflates the chance that the one significant power finding (d=0.90) is a lucky draw. A clinician trying to verify this in practice would need the actual CMJ/power numbers and CIs, not just the p-value, to judge whether the gain is meaningfully large.

Question 4

What is the overall appraisal?

Accepted Answer

The effect size for lower-limb power (d=0.90) looks large, but in a 9-person group that estimate has huge uncertainty, and it didn't translate into better judo-specific performance on the SJFT, where both models were equivalent. That disconnect matters more clinically than the power finding: if the on-mat outcome is identical, the extra autonomic strain from block planning (higher HRVcv) is a cost without a demonstrated benefit for the outcome coaches actually care about. Creatine kinase and TNF-alpha rose over time in both groups rather than more in block planning specifically, and the cortisol interaction had no clear post hoc differences, so the biochemical picture is murkier than the autonomic one and shouldn't be read as a clean block-planning penalty.

Question 5

What is the main limitation?

Accepted Answer

The trial is 4 weeks long with no follow-up into competition or a subsequent training block, so it can't say whether block planning's power gain holds up, decays, or converts into injury or overtraining risk over a full season. The sample is also small and skewed toward men (14 men, 4 women, 9 per arm), so it can't speak to whether the pattern holds for female judokas specifically.

Question 6

What should clinicians do on Monday?

Accepted Answer

Not a reason to change a periodization model on Monday. If anything it's a mild argument for favouring undulating planning in a short in-season block for judokas, since it matched block planning on the judo-specific test with less autonomic disruption, but this is one small trial and shouldn't override a coach's existing athlete-specific monitoring.

Question 7

How do I apply this in practice?

Accepted Answer

Applies to elite and sub-elite combat-sport athletes (judo, wrestling, grappling) training through short in-season strength blocks where mat time and recovery capacity are both limited. On the S&C floor, this isn't grounds to abandon block periodization, but it does support defaulting to undulating/non-linear loading in-season when technical-tactical volume is already high and recovery monitoring is thin, saving concentrated block loading for off-season or pre-competition windows where the extra autonomic cost can be tracked and managed. In the clinic, treat the HRVcv finding as a cue to monitor autonomic load, not just session RPE or jump output, in athletes on short concentrated strength blocks, especially in the weeks before a competition taper. Treat this as one small trial: don't restructure an athlete's whole periodization model on it, and keep individual recovery monitoring as the actual decision driver.

Performance and Physiological Responses to Strength Training Programs in Elite Judo Athletes

The paper

What they found

Study design

Methodology

The appraisal

The gap

Landmark context

What to do Monday

In practice

The five papers that matter — every week, free.

Related appraisals